Skip to main content

Advertisement

Table 3 Facilitators and barriers to the management of PE/E using MgSO4 by type of facility

From: Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study

Item Hospitals (n = 20), % Health centers (n = 60), % Total (n = 80), %
Facilitators    
Attendance of a training on PE/E by SP 60 38.3 43.8
Identification of MgSO4 as first line drug by SP 85 58 65
Availability of service registers in the facility 80 58.3 63.7
Barriers    
Non-availability of MgSO4    
  Reported by SP 15 46.7 38.8
  Facility inventory 35 63.4 56.2
MgSO4 stockout§ in the facilitya 46 33 40
Non-availability of clinical guidelines/protocols in the facility 50 90 80
No supportive supervision received by SP 55 90 81.2
  1. aAmong those that had MgSO4 on the day of survey, N = 35
  2. p-value < 0.05
  3. §Events where supplies were completely exhausted before re-supply
  4. Routine supervisory visits by States’ Ministry of Health officials during which service providers are mentored and provided with technical assistance to improve on their work